Because the A549 NSCLC cell line used in our studies has a WT EGFR phenotype, we speculated whether the apoptotic cell death resulting from the combination treatment might be a novel response of NSCLC cells that exhibit a WT EGFR phenotype. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.